Sample size in cluster-randomized trials with time to event as the primary endpoint

被引:16
|
作者
Jahn-Eimermacher, Antje [1 ]
Ingel, Katharina [1 ]
Schneider, Astrid [1 ]
机构
[1] Johannes Gutenberg Univ Mainz, IMBEI, Med Ctr, D-55131 Mainz, Germany
关键词
sample size; cluster randomized; survival; time to event; correlated; PROPORTIONAL-HAZARDS REGRESSION; SURVIVAL-DATA; COEFFICIENT; IMPROVEMENT; PREVENTION; FORMULA; DISEASE; DESIGN; MODEL; CARE;
D O I
10.1002/sim.5548
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In cluster-randomized trials, groups of individuals (clusters) are randomized to the treatments or interventions to be compared. In many of those trials, the primary objective is to compare the time for an event to occur between randomized groups, and the shared frailty model well fits clustered time-to-event data. Members of the same cluster tend to be more similar than members of different clusters, causing correlations. As correlations affect the power of a trial to detect intervention effects, the clustered design has to be considered in planning the sample size. In this publication, we derive a sample size formula for clustered time-to-event data with constant marginal baseline hazards and correlation within clusters induced by a shared frailty term. The sample size formula is easy to apply and can be interpreted as an extension of the widely used Schoenfeld's formula, accounting for the clustered design of the trial. Simulations confirm the validity of the formula and its use also for non-constant marginal baseline hazards. Findings are illustrated on a cluster-randomized trial investigating methods of disseminating quality improvement to addiction treatment centers in the USA. Copyright (c) 2012 John Wiley & Sons, Ltd.
引用
收藏
页码:739 / 751
页数:13
相关论文
共 50 条
  • [41] Cluster-randomized controlled trials: Part 2
    Pandis, Nikolaos
    [J]. AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS, 2012, 142 (03) : 422 - 423
  • [42] Cluster-Randomized Trials: Methodical and Practical Implications
    Dreyhaupt, Jens
    Mayer, Benjamin
    Kaluscha, Rainer
    Muche, Rainer
    [J]. REHABILITATION, 2020, 59 (01) : 54 - 61
  • [43] Cluster-randomized controlled trials: Part 1
    Pandis, Nikolaos
    [J]. AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS, 2012, 142 (02) : 276 - 277
  • [44] Meta-analysis of cluster-randomized trials
    Spineli, Loukia M.
    Pandis, Nikolaos
    [J]. AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS, 2023, 163 (02) : 288 - 291
  • [45] Thalamic Atrophy as Primary Endpoint for Phase 2 Trials in MS: Sample Size Calculations
    Azevedo, Christina
    Pelletier, Daniel
    [J]. NEUROLOGY, 2016, 86
  • [46] Design and sample size estimation in clinical trials with clustered survival times as the primary endpoint
    Xie, TL
    Waksman, J
    [J]. STATISTICS IN MEDICINE, 2003, 22 (18) : 2835 - 2846
  • [47] Sample size calculations for 3-level cluster randomized trials
    Teerenstra, Steven
    Moerbeek, Mirjam
    van Achterberg, Theo
    Pelzer, Ben J.
    Borm, George F.
    [J]. CLINICAL TRIALS, 2008, 5 (05) : 486 - 495
  • [48] A simple sample size formula for analysis of covariance in cluster randomized trials
    Teerenstra, Steven
    Eldridge, Sandra
    Graff, Maud
    de Hoop, Esther
    Borm, George F.
    [J]. STATISTICS IN MEDICINE, 2012, 31 (20) : 2169 - 2178
  • [49] Sample size calculations for the design of cluster randomized trials: A summary of methodology
    Gao, Fei
    Earnest, Arul
    Matchar, David B.
    Campbell, Michael J.
    Machin, David
    [J]. CONTEMPORARY CLINICAL TRIALS, 2015, 42 : 41 - 50
  • [50] Sample size calculation for cluster randomized cross-over trials
    Giraudeau, B.
    Ravaud, P.
    Donner, A.
    [J]. STATISTICS IN MEDICINE, 2008, 27 (27) : 5578 - 5585